There has been however much attention given to MHC class II expression in various cancer types such as colorectal (168), cervical (169), lung (170), breast (171), melanoma (172) and pancreatic cancer (173), pointing also to the significance of CD4+-mediated anti-tumor responses (174, 175). This evidence concerns the gene CD4 and cancer.